Edwards Lifesciences Corporation is a leading global structural heart innovation company focused on advancing treatments for cardiovascular disease. The company specializes in developing and providing innovative medical technologies for structural heart conditions, including transcatheter heart valves that enable minimally invasive valve replacement procedures. Its product portfolio also encompasses transcatheter mitral and tricuspid technologies for repairing leaking valves without open-heart surgery, surgical valve technologies for traditional replacement options, and implantable heart failure management solutions to support patients with advanced cardiac issues. Edwards Lifesciences Corporation serves clinicians, healthcare systems, and patients worldwide through breakthrough technologies and evidence-based partnerships. Founded in 1958 and headquartered in Irvine, California, it plays a pivotal role in the healthcare equipment sector by delivering life-changing structural heart solutions to those in need.